Needham Reiterates Buy on Boston Scientific, Maintains $82 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Buy rating on Boston Scientific (NYSE:BSX) and maintained a price target of $82.
June 18, 2024 | 5:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a Buy rating on Boston Scientific and maintained a price target of $82.
The reiteration of a Buy rating and the maintenance of a price target at $82 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100